Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Britannia Life Sciences Inc Com C.RLSC

RISE Life Science Corp is engaged in developing and evolving medical and adult hemp-based formulations to create general use of health and well-being products for the emerging consumer category. It derives key revenue from the United States.


CSE:RLSC - Post by User

Comment by Donlinon May 02, 2015 7:52pm
163 Views
Post# 23688679

RE:Glad I bailed on MOM...

RE:Glad I bailed on MOM...I should have bailed at .22.  Now I'm stucked.  Averaging down is NOT an option.  MOM is NOT showing (again) that it can go the distance.

If the success of this company was based on the number of private placements I would be in a profit position.

However, history appears to be repeating itself.  A lot of good words but no bottom line success.  All talk and no walk.  Their other presceening device has fallen on its mechanism and until certain events occur for the Scout I won't be adding to my position.  And believe me, even if these events come thru there is no guarantee.

Approvals, letters of intent, innovation awards, drug store arrangements mean absolutely nothing until the market accepts MOM's successful execution of their marketing plan.

At 10.5 cents there's a chance that history is repeating itself.  FDA and CDFA approvals may not mean a dam if the revenue for these devices does not materialize.
Bullboard Posts